IOBT

0.96

4.03% 0.0372

Vorhandelsmarkt: .93 -0.03 -3.12%

Io Biotech Inc (IOBT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$0.9228

Offen:

$0.93

24-Stunden-Volumen:

213.60K

Relative Volume:

1.33

Marktkapitalisierung:

$58.59M

Einnahmen:

Nettoeinkommen (Verlust:

$-86.08M

KGV:

-0.445

EPS:

-2.1574

Netto-Cashflow:

$-72.06M

1W Leistung:

+11.61%

1M Leistung:

-17.95%

6M Leistung:

-20.66%

1J Leistung:

-33.79%

1-Tages-Spanne:

$0.85

$1.00

1-Wochen-Bereich:

$0.85

$1.00

52-Wochen-Spanne:

$0.66

$1.79

Io Biotech Inc Stock (IOBT) Company Profile

Firmenname

Io Biotech Inc

Sektor

Healthcare (1155)

Branche

Biotechnology (677)

Telefon

(457) 070-2980

Adresse

OLE MAALOES VEH 3, COPENHAGEN

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-31

Neueste SEC-Einreichungen

IOBT's Discussions on Twitter

Vergleichen Sie IOBT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IOBT Io Biotech Inc	0.96	58.59M	0	-86.08M	-72.06M	-2.1574
VRTX Vertex Pharmaceuticals Inc	493.84	122.76B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	602.64	61.38B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	614.76	36.37B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.56	30.12B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	244.90	24.70B	3.81B	-644.79M	-669.77M	-6.24

Io Biotech Inc Aktie (IOBT) Neueste Nachrichten

Apr 26, 2025

IO Biotech's Co-Founder Mads Hald Andersen Highlights Advances in Cancer Vaccine Research at 2025 AACR Annual Meeting - Nasdaq

Apr 26, 2025

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 - The Globe and Mail

Apr 26, 2025

Apr 25, 2025

IO Biotech unveils promising vaccine preclinical data By Investing.com - Investing.com India

Apr 25, 2025

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 - The Manila Times

Apr 25, 2025

Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting - The Manila Times

Apr 25, 2025

New Cancer Vaccine Data Shows Powerful Immune Response in Multiple Tumors | IOBT Stock News - Stock Titan

Apr 25, 2025

Short Sellers Gave Up on These 3 Names Recently - The Globe and Mail

Apr 25, 2025

4 Cheap Stocks With Solid Fundamentals to Offset Market Uncertainty - The Globe and Mail

Apr 25, 2025

Cotton Extending Strength to Friday Morning - The Globe and Mail

Apr 25, 2025

Apr 24, 2025

Healthcare Services (HCSG) Receives a Hold from William Blair - The Globe and Mail

Apr 24, 2025

3 Reasons AMTM is Risky and 1 Stock to Buy Instead - The Globe and Mail

Apr 24, 2025

Apr 23, 2025

Nano One 2025 Annual General Meeting of Shareholders - The Globe and Mail

Apr 23, 2025

Boeing doesn't expect the US trade war with China to slow its recovery - The Globe and Mail

Apr 23, 2025

Apr 22, 2025

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - The Globe and Mail

Apr 17, 2025

Apr 16, 2025

Viking Therapeutics Stock Pops But Struggles to Hold Gains - The Globe and Mail

Apr 16, 2025

Apr 15, 2025

CrowdStrike Stock is a Buy as Cyberthreat Environment Expands - The Globe and Mail

Apr 15, 2025

Apr 14, 2025

5 Top Psychedelic Stocks (2025) for Mental Health Investing - Securities.io

Apr 14, 2025

Apr 12, 2025

We're A Little Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn Rate - Yahoo Finance

Apr 12, 2025

Apr 10, 2025

Metastatic Melanoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Apr 10, 2025

Google (GOOGL) Offers U.S. Government Major Discounts as It Challenges Microsoft - The Globe and Mail

Apr 10, 2025

Seeking High Dividend Yield? Earn 9.6% from This Energy Stock Now. - The Globe and Mail

Apr 10, 2025

Tetra Tech Awarded £36 Million Multiple-Award Contract for Water Infrastructure Services - The Globe and Mail

Apr 10, 2025

Apr 09, 2025

NESR to Participate in Water Tower Research Fireside Chat on April 10 at 11am ET - The Globe and Mail

Apr 09, 2025

Apr 08, 2025

Financial Survey: Vistagen Therapeutics (NASDAQ:VTGN) versus IO Biotech (NASDAQ:IOBT) - Defense World

Apr 08, 2025

WSP Global Inc. (TSE:WSP) Receives C$284.85 Consensus Target Price from Brokerages - Defense World

Apr 08, 2025

Evergy, Inc. (NASDAQ:EVRG) Receives $69.08 Average Price Target from Brokerages - Defense World

Apr 08, 2025

Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $19.11 - Defense World

Apr 08, 2025

Apr 07, 2025

Ag Futures Markets Are Suffering a Severe Case of Tariff Indigestion. When Will They Rebound? - The Globe and Mail

Apr 07, 2025

Apr 06, 2025

Prediction: This Artificial Intelligence (AI) Semiconductor Stock Could Start Soaring After April 16 - The Globe and Mail

Apr 06, 2025

Apr 05, 2025

Q1 Earnings Forecast for IO Biotech Issued By HC Wainwright - Defense World

Apr 05, 2025

Globus Medical acquires Nevro Corp. - Medical Buyer

Apr 05, 2025

Apr 04, 2025

Is Nvidia Stock a Buy or Sell Below $100 as a Global Trade War Escalates? - The Globe and Mail

Apr 04, 2025

Apr 02, 2025

IO Biotech (NASDAQ:IOBT) Given “Buy” Rating at HC Wainwright - Defense World

Apr 02, 2025

Apr 01, 2025

Fresh Quarter, Fresh Momentum? Markets Eye April 2nd Tariff Announcement - The Globe and Mail

Apr 01, 2025

Mar 31, 2025